Announcement
Following the success of Phase 1 of Radiation Assurance, the Health Research Authority (HRA) are inviting further Medical Physical Experts (MPEs) and Clinical Radiation Experts (CREs) to become registered reviewers in preperation for the launch of Phase 2 on Monday 12 November 2018.
The Health Research Authority (HRA) are currently inviting Pharmacists and Pharmacy Technicians to register to become HRA Pharmacy Assurance Reviewers.
The ECMC Programme Office has collated the responses from the adult ECMCs and produced a report which showcases the amount of work being done in this area across the Network. Our main aim in doing this is to support and promote the sharing of knowledge, learning and good practice across the ECMC network and beyond.
In a first of its kind collaboration, research staff from two Welsh Hospitals came together in 2017 to plan the joint delivery of a complex clinical trial for cancer patients. Their efforts have paid off for Welsh patients, and have resulted in being shortlisted for a prestigious Nursing Times award.
Forty-seven delegates from across the research landscape (regulators, trials units, researchers, patients, trust R&D, funders and sponsors) came together on the 27 June 2018 to start work on producing a consensus paper about how we can streamline and promote innovative trials in the UK. The term innovative trials encompasses Platform, Umbrella, Basket, Complex , Adaptive and Modular trials.
NHS England with the NIHR are aiming to create a process that costs a multi-centre commercial project once only. The ambition being that this will speed up the set-up time and equalise out the variance in costs up and down the country, making the UK a more attractive place to bring research.
In June 2018, two currently open trials within the CRUK Combinations Alliance Portfolio have successfully defined their recommended phase 2 dose within the Dose Escalation Phase of the Trial, and have now opened their randomised expansion cohorts to patients in the target cancer type and setting via the ECMC network.
A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance(link is external), a joint initiative between Cancer Research UK and our ECMC network, today.
Research nurses are a vital part of the ECMC network and last month (April), the Programme Office held a training day for research nurses who are new to working in early phase cancer research. The aim of the day was to equip new early phase research nurses to deliver high quality, patient-centred care, within the regulatory framework. Twenty-five new research nurses were joined by eleven senior research nurses in Edinburgh to share their experiences and any apprehensions about such a demanding role.